1. 11-Hydroxylation of Protoberberine by the Novel Berberine-Utilizing Aerobic BacteriumSphingobiumsp. Strain BD3100
    Hisashi Takeda et al, 2015, J. Nat. Prod. CrossRef
  2. Multiple Effects of Berberine Derivatives on Colon Cancer Cells
    Luis Miguel Guamán Ortiz et al, 2014, BioMed Research International CrossRef
  3. Berberine induces FasL-related apoptosis through p38 activation in KB human oral cancer cells
    JAE-SUNG KIM et al, 2015 CrossRef
  4. Berberine as an Adjuvant and Sensitizer to Current Chemotherapy
    Alok Chandra Bharti et al, 2018 CrossRef
  5. Berberine, an Epiphany Against Cancer
    Luis Guamán Ortiz et al, 2014, Molecules CrossRef
  6. Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth
    Stefania Ferrari et al, 2018 CrossRef
  7. Synthesis, molecular structure exploration and in vitro cytotoxicity screening of five novel N, N'- disubstituted thiocarbamide derivatives
    Sunil K. Pandey et al, 2018, Phosphorus, Sulfur, and Silicon and the Related Elements CrossRef
  8. Effects of berberine on tumor growth and intestinal permeability in HCT116 tumor-bearing mice using polyamines as targets
    Yan-Yan Wu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  9. Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells
    Stephen L. Abrams et al, 2018, Advances in Biological Regulation CrossRef
  10. Aberrant Expression of Folate Metabolism Enzymes and Its Diagnosis and Survival Prediction in Ovarian Carcinoma
    Jia Chen et al, 2019, Analytical Cellular Pathology CrossRef
  11. Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells
    Shaw M. Akula et al, 2019, Advances in Biological Regulation CrossRef
  12. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
    Li Liu et al, 2019, Biol Res CrossRef
  13. N-ω-chloroacetyl-l-ornithine, a new competitive inhibitor of ornithine decarboxylase, induces selective growth inhibition and cytotoxicity on human cancer cells versus normal cells
    Miriam Marlene Medina-Enríquez et al, 2015, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
  14. Recognition of human telomeric G-quadruplex DNA by berberine analogs: effect of substitution at the 9 and 13 positions of the isoquinoline moiety
    Debipreeta Bhowmik et al, 2015, J. Mol. Recognit. CrossRef
  15. Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives
    Ning Wang et al, 2015, Journal of Ethnopharmacology CrossRef
  16. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Gaetano Marverti, 0 CrossRef
  17. Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth.
    Gaetano Marverti, 0 CrossRef
  18. Anticancer activities and mechanisms of heat-clearing and detoxicating traditional Chinese herbal medicine
    Yulin Zhang et al, 2017, Chin Med CrossRef
  19. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.
    Hua Luo et al, 2019, Chin Med CrossRef
  20. Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance
    Hamed Mortazavi et al, 2019, European Journal of Medicinal Chemistry CrossRef
  21. The 1,10-Phenanthroline Ligand Enhances the Antiproliferative Activity of DNA-Intercalating Thiourea-Pd(II) and -Pt(II) Complexes Against Cisplatin-Sensitive and -Resistant Human Ovarian Cancer Cell Lines.
    Gaetano Marverti, 0 CrossRef
  22. Characterization of Burkholderia sp. strain CJ1, a newly isolated berberine-degrading bacterium from rhizosphere of Coptis japonica
    Hinaka Yoshida et al, 2020, Bioscience, Biotechnology, and Biochemistry CrossRef

  23. In vitro Multistage Malaria Transmission Blocking Activity of Selected Malaria Box Compounds


    Hamisi M Malebo et al, 2020, DDDT CrossRef
  24. Berberine inhibits the LPS‑induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling pathway
    Li Liu et al, 2017, Exp Ther Med CrossRef
  25. Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
    James A. McCubrey et al, 2017, Aging CrossRef
  26. Berberine inhibited metastasis through miR-145/MMP16 axis in vitro
    Jie Li et al, 2021, J Ovarian Res CrossRef
  27. Berberine—A potent chemosensitizer and chemoprotector to conventional cancer therapies
    Nalini Devarajan et al, 2021, Phytotherapy Research CrossRef
  28. Folic Acid–Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting
    Gaetano Marverti et al, 2021, J. Med. Chem. CrossRef
  29. Berberine, a potential prebiotic to indirectly promote Akkermansia growth through stimulating gut mucin secretion
    Chaoran Dong et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  30. Structural Bases for the Synergistic Inhibition of Human Thymidylate Synthase and Ovarian Cancer Cell Growth by Drug Combinations.
    Gaetano Marverti, 0 CrossRef
  31. Inhibitory effects of berberine on ovarian cancer: Beyond apoptosis
    Parisa Maleki Dana et al, 2021, Med Chem Res CrossRef
  32. APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells
    James Andrew McCubrey et al, 2022, Biomolecules CrossRef
  33. Dihydrofolate reductase, thymidylate synthase, and serine hydroxy methyltransferase: successful targets against some infectious diseases
    Hina Shamshad et al, 2022, Mol Biol Rep CrossRef
  34. Nano Metal Based Herbal Theranostics for Cancer Management: Coalescing Nature’s Boon with Nanotechnological Advancement
    Yogesh Pandey et al, 2022, CPB CrossRef
  35. Targeting purine metabolism in ovarian cancer
    Jingchun Liu et al, 2022, J Ovarian Res CrossRef
  36. Berberine enhances the sensitivity of radiotherapy in ovarian cancer cell line (SKOV-3)
    Mohammed S. Aleissa et al, 2022, Saudi Pharmaceutical Journal CrossRef
  37. Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth
    Luca Costantino et al, 2022 CrossRef
  38. c-MYC-Driven Polyamine Metabolism in Ovarian Cancer: From Pathogenesis to Early Detection and Therapy
    Yihui Chen et al, 2023, Cancers CrossRef
  39. Expression analysis of DHFR and PTR1 genes in Leishmania major expose to olive leaf extract
    Elnaz Bafandeh et al, 2023, South African Journal of Botany CrossRef
  40. Polyamines in Ovarian Aging and Disease
    Bo Kang et al, 2023, IJMS CrossRef
  41. Antitumor Effect of Berberine Analogs in a Canine Mammary Tumor Cell Line and in Zebrafish Reporters via Wnt/β-Catenin and Hippo Pathways
    Alessandro Sammarco et al, 2023, Biomedicines CrossRef
  42. Unlocking the potential of Berberine: Advancing cancer therapy through chemosensitization and combination treatments.
    Anjana Sajeev et al, 2024, Cancer Lett CrossRef
  43. Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization
    Solomon Habtemariam, 2020, Molecules CrossRef
  44. A nanoscale natural drug delivery system for targeted drug delivery against ovarian cancer: action mechanism, application enlightenment and future potential
    Yi Li et al, 2024, Front. Immunol. CrossRef
  45. Pyrogallol acts as a novel anticancer factor to enhance the sensitivity to cisplatin in ovarian cancer cells through inducing miR-15a upregulation
    Azin Shirani et al, 2025, Egypt J Med Hum Genet CrossRef